- 2025/07/05
- Category :
[PR]
[PR]上記の広告は3ヶ月以上新規記事投稿のないブログに表示されています。新しい記事を書く事で広告が消えます。
プレスリリース、開示情報のアーカイブ
[PR]上記の広告は3ヶ月以上新規記事投稿のないブログに表示されています。新しい記事を書く事で広告が消えます。
“For BRAIN, the collaboration announced today is another proof of the versality and creativity of biology and especially of the microorganisms. We are glad, that leading chemical corporations use our “toolbox of nature”
Within the co-operation the partners pursue the joint objective of identifying and developing suitable microorganisms, which, by using their adsorption properties, will specifically introduce novel physical properties to the selected surfaces.
It is the goal of the partners to integrate the selected microorganisms into an industrial-scale. BRAIN will contribute its expertise in biotechnology, microbiology and the development of pilot processes, while Evonik shall be responsible for the technical implementation and marketing of the products. Financial terms of the collaboration or more detailed technical information are not disclosed.
“For BRAIN, the collaboration announced today is another proof of the versality and creativity of biology and especially of the microorganisms. We are glad, that leading chemical corporations use our “toolbox of nature” with the goal to increase the value of the corporation”, says Dr. Holger Zinke, Chief Executive Officer of BRAIN. ”We see an enormous potential for synergies in the co-operation, allowing us to combine the technologies of BRAIN with Evonik Industries’ development and marketing expertise to excellent effect."
BRAIN
Biotechnology Research
And Information Network AG
Dr. Martin Langer
Corporate Development
Tel.: +49-(0)-6251-9331-16
Fax.: +49-(0)-6251-9331-11
E-Mail: ml@brain-biotech.de
www.brain-biotech.de